A detailed history of Td Asset Management Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 73,548 shares of ARVN stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,548
Previous 91,548 19.66%
Holding current value
$1.9 Million
Previous $2.44 Million 25.69%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$23.66 - $32.73 $425,880 - $589,140
-18,000 Reduced 19.66%
73,548 $1.81 Million
Q2 2024

Aug 02, 2024

SELL
$24.46 - $40.4 $2.64 Million - $4.36 Million
-107,800 Reduced 54.08%
91,548 $2.44 Million
Q1 2024

May 08, 2024

BUY
$36.38 - $52.31 $1.91 Million - $2.74 Million
52,400 Added 35.66%
199,348 $8.23 Million
Q4 2023

Feb 12, 2024

BUY
$14.19 - $42.33 $738,958 - $2.2 Million
52,076 Added 54.89%
146,948 $6.05 Million
Q3 2023

Oct 27, 2023

BUY
$19.64 - $28.21 $931,643 - $1.34 Million
47,436 Added 100.0%
94,872 $1.86 Million
Q2 2023

Aug 09, 2023

SELL
$21.73 - $31.43 $313,781 - $453,849
-14,440 Reduced 23.34%
47,436 $1.18 Million
Q1 2023

May 10, 2023

BUY
$26.15 - $37.26 $39,225 - $55,890
1,500 Added 2.48%
61,876 $1.69 Million
Q4 2022

Feb 06, 2023

BUY
$32.47 - $57.24 $6,494 - $11,448
200 Added 0.33%
60,376 $2.07 Million
Q2 2022

Aug 04, 2022

SELL
$36.01 - $74.24 $165,429 - $341,058
-4,594 Reduced 7.09%
60,176 $2.53 Million
Q1 2022

May 10, 2022

SELL
$60.27 - $81.57 $120,901 - $163,629
-2,006 Reduced 3.0%
64,770 $4.36 Million
Q4 2021

Feb 10, 2022

BUY
$65.85 - $96.21 $875,014 - $1.28 Million
13,288 Added 24.84%
66,776 $5.49 Million
Q2 2021

Aug 11, 2021

SELL
$60.45 - $84.26 $307,206 - $428,209
-5,082 Reduced 8.68%
53,488 $5.41 Million
Q1 2021

May 14, 2021

BUY
$58.19 - $91.37 $547,917 - $860,339
9,416 Added 19.16%
58,570 $3.87 Million
Q4 2020

Feb 16, 2021

BUY
$20.19 - $84.93 $574,486 - $2.42 Million
28,454 Added 137.46%
49,154 $4.18 Million
Q3 2020

Nov 10, 2020

BUY
$22.99 - $36.34 $133,342 - $210,772
5,800 Added 38.93%
20,700 $489,000
Q2 2020

Aug 13, 2020

BUY
$29.88 - $56.74 $292,824 - $556,052
9,800 Added 192.16%
14,900 $500,000
Q1 2020

May 15, 2020

BUY
$33.0 - $54.5 $168,300 - $277,950
5,100 New
5,100 $206,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.38B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.